Mitogen-activated protein kinases as glucose transducers for diabetic complications.
about
The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cellsBasic Properties of the p38 Signaling Pathway in Response to Hyperosmotic ShockRetinal insulin receptor signaling in hyperosmotic stressO-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2Phospho-Site-Specific Antibody Microarray to Study the State of Protein Phosphorylation in the Retina.The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy.Evaluation of the effects of novel nafimidone derivatives on thermal hypoalgesia in mice with diabetic neuropathy.Epidemiology of diabetic retinopathy and macular oedema: a systematic review.The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD RatsMesangial cell protein kinase C isozyme activation in the diabetic milieu.Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF.Chronic diabetic complications: the body's adaptive response to hyperglycemia gone awry?Diabetic kidney disease: impact of puberty.The impact of low-dose insulin on peripheral nerve insulin receptor signaling in streptozotocin-induced diabetic rats.Effect of hyperketonemia (Acetoacetate) on nuclear factor-κB and p38 mitogen-activated protein kinase activation mediated intercellular adhesion molecule 1 upregulation in endothelial cellsInactivation of TNF-α ameliorates diabetic neuropathy in mice.Aldose reductase expression as a risk factor for cataractInvolvement of the intrarenal renin-angiotensin system in experimental models of glomerulonephritis.Agents in development for the treatment of diabetic nephropathy.Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.Comprehensive analysis of the mouse renal cortex using two-dimensional HPLC - tandem mass spectrometry.Pathogenesis of diabetic neuropathy: bad to the bone.The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats.Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice.Cellular signaling and potential new treatment targets in diabetic retinopathy.Arjunolic acid: beneficial role in type 1 diabetes and its associated organ pathophysiology.Mechanism of diabetic neuropathy: Where are we now and where to go?Doxazosin attenuates renal matrix remodeling mediated by anti-α1-adrenergic receptor antibody in a rat model of diabetes mellitus.Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells.Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways.Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide.Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis.Reappraisal of metallothionein: Clinical implications for patients with diabetes mellitus.Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model.Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.Antioxidants N-acetyl-L-cysteine and manganese(III)tetrakis (4-benzoic acid)porphyrin do not prevent beta-cell dysfunction in rat islets cultured in high glucose for 1 wk.High glucose-induced inhibition of 2-deoxyglucose uptake is mediated by cAMP, protein kinase C, oxidative stress and mitogen-activated protein kinases in mouse embryonic stem cells.NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes.Modulation of Advanced Glycation End Products, Sorbitol, and Aldose Reductase by Hydroalcohol Extract of Lagenaria siceraria Mol Standl in Diabetic Complications: An In Vitro Approach.
P2860
Q28476375-54F540B7-2862-4708-89AD-0B8AC69BF194Q28547726-B0F263C9-806C-4924-806F-1BEC4BC58A77Q28568662-F7378424-C542-4C60-8D0D-BC4F4BF4F79DQ28580810-17A0E27F-9B22-485C-A4C3-79F80E5ED69EQ33642984-6A2C36F5-B458-48AB-A1BE-1B619AFC97ACQ33933972-107990A8-3D33-48F7-92E9-476DD7015B9CQ33974393-BD72A202-7E49-441C-BF9A-CB8F5F4E2F8DQ34330907-D76913F1-30A1-4C70-BB02-5C84ADFAA267Q34567914-992AB758-0FAD-4F86-9112-031A7D58B2B8Q34629037-10D24FD3-17A3-463E-8FF2-71E314299054Q34733351-3F71DA16-A4E4-4D7E-B892-750AA774EC2AQ34767192-3F550498-EAFF-4B05-AF0F-023144C2C3FBQ34826667-B1AF425C-B421-48D2-BD3B-B5FF090D5B64Q34983794-EF3D26F0-0680-4572-8103-2AF96EE67E99Q35428861-44BE8BFE-0765-4407-9F73-623154AD5635Q35543628-8D3356A7-F7D0-466A-8066-80A38FB5A523Q35554064-47BCA28E-6A0E-45CE-BFC8-BDD87FE53E9EQ36091351-8AED389D-C3ED-4A9A-8EFD-55074FDE8440Q36099419-95E7448D-FB95-40F6-8DD2-DDD0F9CA5418Q36256287-CC4C929F-98B4-4417-BB5A-F2B46AD92D54Q36498308-B4A2013A-EF3C-4B23-93BE-75DB821C4308Q36699386-20134105-8669-4628-9342-B1FD9707051EQ36796321-8B0F5A19-084F-42A4-B5C3-873DB474D054Q36880835-7B562DC3-7A42-41A4-9833-6CF930359537Q36904857-3B38DCB8-7EFD-4E22-8C3A-7536C2C7CA48Q37089750-02C2C10B-A116-438A-A623-84C558456195Q38001051-B2215970-47B0-4BEA-B0A3-3A915FAEB12FQ38213041-6646B6AC-340E-4CD0-8EAB-A78BA943B78CQ41672015-80DAACA8-9014-4CEB-868A-F647BB78F831Q42129552-F866D529-D772-49E8-BE4F-53BC610B5AB1Q42215654-EF445916-4E29-41DF-893B-1D99DEC3802AQ44744482-3A3FEFE2-197D-41F7-A7B4-D0A41B42895AQ45078376-77FEA0A0-88ED-4D02-9C88-9C3E18FE46FBQ46274356-442BF439-A81A-449E-8502-3BEC501D9003Q46665032-39F276B0-F424-41AC-9FC3-F5ACD7813098Q46905338-B167C03E-B04C-4939-8A47-C43F6CD74E8DQ46933169-F6E9A466-C9B0-4D4A-BFB6-B993972AC5EBQ46951093-9B196EF4-BF5A-4E33-AE28-0C8B4E9B0B17Q47094741-D7FE6635-1A1E-48DF-8160-4DF6FE4C5865Q48277155-5CC4767C-3A73-4235-89F2-20FAAAAFB977
P2860
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
@ast
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
@en
type
label
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
@ast
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
@en
prefLabel
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
@ast
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
@en
P356
P1433
P1476
Mitogen-activated protein kinases as glucose transducers for diabetic complications.
@en
P2093
Tomlinson DR
P2888
P304
P356
10.1007/S001250051439
P577
1999-11-01T00:00:00Z
P5875
P6179
1032037949